Life ScienceCompany
CLL Pharma - Opioid Agonist Ownership
Who owns CLL Pharma - Opioid Agonist?
CLL Pharma - Opioid Agonist is owned by BTG. It was acquired on February 20, 2007.
CLL Pharma - Opioid Agonist Business Overview
Where is CLL Pharma - Opioid Agonist headquartered?
CLL Pharma - Opioid Agonist is headquartered in France.
What sector is CLL Pharma - Opioid Agonist in?
CLL Pharma - Opioid Agonist is a life science company.
Life Science M&A Summary in 2007
Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2007. The largest life science acquisition in 2007 was Organon BioSciences N.V. - which was acquired by Schering-Plough for $12.4B.
Join Mergr to view all 131 acquisitions of life science companies in 2007, including 29 acquisitions by private equity firms, and 102 by strategics.